# Evaluation of Exenatide in Patients With Diabetic Neuropathy

> **NCT00855439** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 46 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Glargine

## Key facts

- **NCT ID:** NCT00855439
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-03-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855439, "Evaluation of Exenatide in Patients With Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00855439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*